Machine Learning for Cancer Drug Combination

Y.G. receives personal payment from Eli Lilly and Company, Genentech Inc., F. Hoffmann-La Roche AG, and Cleerly Inc.; holds equity shares at Cleerly Inc., and Ann Arbor Algorithms Inc.; receives research support from Merck KGaA as research contracts and Ryss Tech as unrestricted donations. All other authors declared no competing interests for this work. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.